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ithout kinetochores, cells 
wouldn’t get far in separating 
their chromosomes during 
mitosis. This intricate network of around 
100 proteins assembles at the centromere 
of every chromatid and attaches them to 
the mitotic spindle, aligning them at the 
center before partitioning them to the 
poles during anaphase. But kinetochores 
are much more than a simple link between 
DNA and microtubules—they coordinate 
chromosome and spindle dynamics, and 
are signaling centers that ensure the fi  delity 
of chromosome inheritance.
Iain Cheeseman has been fasci-
nated by the kinetochore since his days 
as a graduate student with David Drubin 
and Georjana Barnes at the University of 
California, Berkeley, where he identifi  ed 
a subgroup of kinetochore proteins called 
the Dam1 complex that links yeast chro-
mosomes to the mitotic spindle (1–3). 
Cheeseman switched to C. 
elegans and human kineto-
chores for his postdoctoral 
studies, working with Arshad 
Desai at the Ludwig Institute 
for Cancer Research, in San 
Diego, CA. He purifi  ed a set 
of kinetochore proteins, called 
the KMN network, which 
forms the core microtubule-
attachment site on metazoan 
chromosomes (4, 5), and con-
trols kinetochore assembly (6). Cheeseman 
began his own laboratory at the Whitehead 
Institute and the Biology Department at 
MIT in Cambridge, MA, in 2007 and re-
cently characterized another kinetochore 
subcomplex that helps chromosomes move 
during anaphase by clinging on to depo-
lymerizing spindle fi  bers (7).
Cheeseman believes that the kineto-
chore parts list is nearing completion, and 
he is excited to begin understanding how 
they all combine to direct chromosome 
segregation. In a recent interview, he 
explained  his long-standing attachment 
to kinetochores, and where his research is 
likely to be pulled next.
EARLY SPECIFICATION
What do you think you’d do if you 
weren’t running a laboratory?
My friends from grad school are doing very 
diverse jobs. Some of them are in academic 
science, but some are teaching high school. 
Some of them work at journals or in bio-
tech. I think all of those things are great 
ways to pursue science. If academia hadn’t 
worked out the way that it has so far, I would 
be really happy doing any of those things.
What were some of your earliest 
scientiﬁ  c experiences?
I grew up in a university town—my father’s 
a professor of plant biology—so in sum-
mers during high school, as well as mow-
ing lawns and things like that, I worked in 
laboratories, washing dishes and making 
solutions. I really liked being around the 
laboratories, so in college, I worked in a 
different laboratory nearly every year: 
plant laboratories, bacteri-
ophage,  Chlamydomonas. 
One summer I worked in a 
honey bee laboratory on cir-
cadian rhythms. We watched 
the bees 24 hours a day. Since 
I was the young kid, they gave 
me the 9 p.m. to 9 a.m. time 
point! It was fun trying differ-
ent things. I think it gave me a 
good idea of what I liked and 
what I didn’t. Often learning 
what you don’t like is an easier way to 
defi  ne the kind of problems that do interest 
you. Basic research questions about how 
something worked always excited me so it 
was an easy choice to go to grad school.
BECOMING ATTACHED
Did you intend to work on 
kinetochores as a student in the 
Drubin/Barnes Laboratory?
Georjana’s focus had been on microtu-
bules. The Dam1 proteins—at least the 
two that had been identifi  ed—came out of 
a screen for cytoskeletal components.
For the fi  rst year and a half, I fo-
cused on the role of these proteins as 
cytoskeletal  elements. But a lot of the 
data that we found were consistent with a 
second role, directing chromosome segre-
gation in a way that you wouldn’t see for 
a purely microtubule-binding protein. It 
took a while to convince people, but it 
became clear that they were actually at the 
kinetochore. After that, I really wanted to 
take more directed approaches to the entire 
thing—thinking of the diversity of things 
that the kinetochore does, it really felt like 
a compelling structure that I could study 
for a long time. I decided to do a postdoc 
in a kinetochore laboratory, partly because 
I came to it a little bit later in my PhD.
You joined Arshad Desai’s laboratory 
in San Diego. What was that like?
I arrived in Arshad’s laboratory after he 
had been there for less than a month. For 
the fi  rst experiments that I did, I had to 
unpack the gel power supply before I 
could run the gel. Seeing things from the 
beginning gave me a nice perspective on 
how to start my own laboratory someday. 
I saw the startup process and the decisions 
that he made, what worked well and occa-
sionally what didn’t.
Arshad’s laboratory was a really fan-
tastic place to work. He is very creative and 
thoughtful about how to approach a prob-
lem, was a lot of fun to argue with, and was 
very supportive. I also had the pleasure of 
working with exceptional laboratory col-
leagues, including Paul Maddox and Reto 
Gassman, and amazing people next door 
in the Oegema and Cleveland laboratories. 
J
O
H
N
 
S
O
A
R
E
S
/
W
H
I
T
E
H
E
A
D
 
I
N
S
T
I
T
U
T
E
Cheeseman is looking forward to a new era of research on 
chromosome segregation.
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It made for a really dynamic environment 
where there was always exciting science 
and diverse perspectives.
What is it that fascinates you about 
the kinetochore?
The most exciting thing to me is that the 
kinetochore has so many different activi-
ties that it’s almost a model for anything 
that you could want to study in cell biol-
ogy. It’s such a complex and intricate 
structure that there are a lot of exciting 
questions to answer about it.
Even going back 100 years, there 
was a good understanding of what a kine-
tochore is and for the next, say, 60 years 
people were able to learn a huge amount 
from just watching how the chromosomes 
behaved. It wasn’t until 1987 that the fi  rst 
human kinetochore protein was identifi  ed. 
For the next 10 years, it was like pulling 
teeth to fi   nd other components of the 
structure. But from about 2000 to 2007 it 
exploded, going from 10 proteins to 80. 
We contributed a lot to that by pulling 
down tagged proteins from yeast, worms, 
and human cells. However, it’s started to 
level off in the past couple of years, which 
makes me think that we’re getting to the 
end of this phase.
Consider all the things a kineto-
chore does: binding to DNA, specifying 
a position on the chromosome, binding 
to microtubules, sensing and correcting 
defects, assembling and disassembling 
the kinetochore during the cell cycle. You 
could guess the players most likely to be 
involved in each of these functions, but we 
have no idea how they work. Now you have 
this parts list, however, you can direct your 
experiments in a really intelligent way. You 
can understand the individual functions of 
the proteins and how they integrate to facil-
itate chromosome segregation. This really 
is the golden age of the kinetochore.
MAKING THE SEPARATION
What’s next for your laboratory?
The last paper I published in grad school 
looked at kinetochore regulation, and that is 
something I’ve always been really excited 
about. Not only do you have to physically 
segregate chromosomes, you have to con-
trol it in such a way that it never produces 
errors. The phosphorylation events that alter 
the behavior or assembly of the kinetochore 
are almost completely unknown.
We’re starting to sort through that. 
Not only is it a great way to defi  ne regu-
latory paradigms, but we can also learn 
how an individual protein works mech-
anistically. For example, Aurora B is a 
master regulatory kinase in kinetochores 
that phosphorylates Ndc80 to turn off its 
microtubule-binding activity. If you didn’t 
know anything about Ndc80 to begin with, 
it would tell you a lot about how it works, 
because those phosphorylation sites occur 
in a very short stretch of the protein’s N 
terminus that binds microtubules.
A lot of your work has focused on 
the attachment of kinetochores to 
microtubules…
That’s always fascinated me. You have lots 
of different players at the microtubule inter-
face. There’s the KMN network, of which 
Ndc80 is a part, which really forms the core 
attachment to microtubules that resists the 
huge forces generated during 
mitosis. Then there’s the Ska1 
complex, which helps hold 
onto a microtubule as it de-
polymerizes, harnessing that 
energy to move the chromo-
somes. You have motors like 
CENP-E and dynein that 
drive translocation along the microtubule 
polymer and factors that direct microtubule 
dynamics: CLASP guides polymerization 
of kinetochore-bound microtubules, while 
MCAK destabilizes them.
So there are lots of individual activi-
ties that you need to defi  ne, but ultimately 
we have to integrate all of them—determine 
how they fi  t into this larger structure and 
work together. We’re trying to understand 
more about how the KMN and Ska1 com-
plexes work. Although they’re very different 
in their properties and cellular phenotypes, 
I would be hard-pressed to draw a tight 
line between their functions. They’re both 
amazing machines; we need to fi  gure out 
how they coordinate with each other.
Do you only work with human cells now?
Arshad was really generous in letting me 
take the projects that I had set up and a lot 
of that was in human cells. It was a nice 
way to go our separate ways, as he con-
tinues to focus on worms.
Lots of human kinetochore proteins 
don’t exist in C. elegans and I was curi-
ous about how they work. And it would be 
technically much harder to study kineto-
chore regulation in C. elegans. It’s easier 
to map the phosphorylation sites and look 
at their function in human cells. So it re-
ally made sense; I’d say 98% of what we 
do now is in human cells. But there are 
places where C. elegans or yeast are better 
suited to a particular experiment, so when 
we come across those specifi  c questions, 
we’ll move to a different organism.
We don’t want to be limited by ap-
proach. If it makes sense to do biochemis-
try, we’ll do biochemistry. If it makes sense 
to do cell biology, we’ll do cell biology. The 
back and forth between approaches is really 
important. If you have a phenotype or local-
ization that says something about a protein, 
it really guides your choice of biochemical 
assays. But once you’ve done the biochem-
istry, being able to go back and test whether 
the things you’ve learned are 
really important to the cell is 
also very useful.
Similarly, if it makes 
sense to crystallize some-
thing or learn how to do sin-
gle molecule studies, we’ll 
fi  gure out how to go in that 
direction. The people I get to work with 
are really smart, they work their butt off, 
and they do fantastic stuff. I love working 
with the people in my laboratory.
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Spindle microtubules (green) attach to kineto-
chores (red) on the chromosomes (blue) of a 
mitotic HeLa cell.
“This really 
is the golden 
age of the 
kinetochore.”